Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEY... von Antonarakis, Emmanuel S, Park, Se Hoon, Goh, Jeffrey C, Shin, Sang Joon, Lee, Jae Lyun, Mehra, Niven, McDermott, Ray, Sala-Gonzalez, Núria, Fong, Peter C, Greil, Richard, Retz, Margitta, Sade, Juan Pablo, Yanez, Patricio, Huang, Yi-Hsiu, Begbie, Stephen D, Gafanov, Rustem Airatovich, De Santis, Maria, Rosenbaum, Eli, Kolinsky, Michael P, Rey, Felipe, Chiu, Kun-Yuan, Roubaud, Guilhem, Kramer, Gero, Sumitomo, Makoto, Massari, Francesco, Suzuki, Hiroyoshi, Qiu, Ping, Zhang, Jinchun, Kim, Jeri, Poehlein, Christian H, Yu, Evan Y

Volltext

Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study von Ciuleanu, Tudor, MD, Brodowicz, Thomas, MD, Zielinski, Christoph, Prof, Kim, Joo Hang, MD, Krzakowski, Maciej, Prof, Laack, Eckart, MD, Wu, Yi-Long, Prof, Bover, Isabel, MD, Begbie, Stephen, MD, Tzekova, Valentina, MD, Cucevic, Branka, MD, Pereira, Jose Rodrigues, MD, Yang, Sung Hyun, MD, Madhavan, Jayaprakash, MD, Sugarman, Katherine P, MD, Peterson, Patrick, PhD, John, William J, MD, Krejcy, Kurt, MD, Belani, Chandra P, Dr

Volltext

Health-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUP von Stockler, Martin R, Martin, Andrew J, Davis, Ian D, Dhillon, Haryana M, Begbie, Stephen D, Chi, Kim N, Chowdhury, Simon, Coskinas, Xanthi, Frydenberg, Mark, Hague, Wendy E, Horvath, Lisa G, Joshua, Anthony M, Lawrence, Nicola J, Marx, Gavin M, McCaffrey, John, McDermott, Ray, McJannett, Margaret, North, Scott A, Parnis, Francis, Parulekar, Wendy R, Pook, David W, Reaume, M Neil, Sandhu, Shahneen, Tan, Alvin, Tan, Thean Hsiang, Thomson, Alastair, Vera-Badillo, Francisco, Williams, Scott G, Winter, Diana G, Yip, Sonia, Zhang, Alison Y, Zielinski, Robert R, Sweeney, Christopher J

Volltext

Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial von Araujo, John C, Dr, Trudel, Géralyn C, PhD, Saad, Fred, Prof, Armstrong, Andrew J, MD, Yu, Evan Y, MD, Bellmunt, Joaquim, MD, Wilding, George, Prof, McCaffrey, John, Prof, Serrano, Sergio V, MD, Matveev, Vsevolod B, Prof, Efstathiou, Eleni, MD, Oudard, Stephane, Prof, Morris, Michael J, MD, Sizer, Bruce, MBChB, Goebell, Peter J, MD, Heidenreich, Axel, Prof, de Bono, Johann S, Prof, Begbie, Stephen, MBBS, Hong, Jun H, MD, Richardet, Eduardo, MD, Gallardo, Enrique, MD, Paliwal, Prashni, PhD, Durham, Susan, BA, Cheng, Shinta, MD, Logothetis, Christopher J, Prof

Volltext

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a... von Cescon, David W, Nowecki, Zbigniew, Gallardo, Carlos, Holgado, Esther, Iwata, Hiroji, Masuda, Norikazu, Otero, Marco Torregroza, Loi, Sherene, Guo, Zifang, Gonzalo, Gomez Abuin, Diego, Kaen, Matias, Molina, Stephen, Begbie, Philip, Clingan, Sherene, Loi, Dhanusha, Sabanathan, Donatienne, Taylor, Domicio Carvalho, Lacerda, Fernando Cezar Toniazzi, Lissa, Felipe, Silva, Joanne, Yu, Alejandro, Acevedo, Bohuslav, Melichar, Katarina, Petrakova, Jana, Prausova, Erik, Jakobsen, Jeanette, Jensen, Soren, Linnet, Tamas, Lorincz, Herve, Bonnefoi, Isabelle, Desmoulins, Jens-Uwe, Blohmer, Nadia, Harbeck, Jens, Huober, Christian, Kurbacher, Sibylle, Loibl, Tibor, Csoszi, Zsuzsanna, Kahan, Karoly, Mahr, John, Crown, Seamus, O'Reilly, Takaaki, Fujii, Hiroji, Iwata, Hirofumi, Mukai, Seigo, Nakamura, Shoichiro, Ohtani, Akihiko, Osaki, Yasuaki, Sagara, Masato, Takahashi, Koichiro, Tsugawa, Junichiro, Watanabe, Yutaka, Yamamoto, Teruo, Yamauchi, Angel, Gomez Villanueva, Alejandro, Juarez Ramiro, Flavia, Morales-Vasquez, David, Porter, Ewa, Chmielowska, Ewa, Nowakowska-Zajdel, Zbigniew, Nowecki, Barbara, Radecka, Joanna, Streb, Alexander, Arkhipov, Natalia, Fadeeva, Oleg, Lipatov, Kwong Hwa, Park, Yeon Hee, Park, Begona, Bermejo de las Heras, Javier, Cortes, Luis, de la Cruz Merino, Jose, Garcia Saenz, Maria, Gion, Mei-Ching, Liu, Chiun-Sheng, Huang, Cagatay, Arslan, Irfan, Cicin, Erhan, Gokmen, Ozgur, Ozyilkan, Sinan, Yavuz, Janine, Graham, Mark, Tuthill, Christopher, Twelves, Duncan, Wheatley, Oleksii, Kolesnik, Olena, Kolesnik, Alla, Nasonova, Olga, Ponomarova, Dmytro, Trukhin, Sibel, Blau, Madhu, Chaudhry, Scott, Cole, William, Irvin, Randa, Loutfi, Janice, Lu, Coral, Omene, Timothy, Panella, Michael, Schleider, Robert, Siegel, Michael, Simon, Frances, Valdes-Albini

Volltext

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomise... von Ueno, Makoto, Finn, Richard S, Ren, Zhenggang, Yau, Thomas, Klümpen, Heinz-Josef, Chan, Stephen L, Park, Joon Oh, Pelzer, Uwe, Yu, Li, Siegel, Abby B, Edeline, Julien, Akce, Mehmet, Asselah, Jamil, Assenat, Eric, Aubin, Francine, Barajas, Olga, Ben-Aharon, Irit, Beri, Nina, Berres, Marie-Luise, Brandi, Giovanni, Butthongkomvong, Kritiya, Camandaroba, Marcos, Carballido, Marcela, Chan, Stephan Lam, Chen, Jen-Shi, Chen, Xiaoming, Chon, Hong Jae, Cubillo Gracian, Antonio, Davis, Sarah, De Vos, Judith, Falcone, Alfredo, Fernandez, Plinio, Finn, Richard, Franke, Fabio, Furukawa, Masayuki, Furuse, Junji, Geboes, Karen, Geng, Zhimin, Geva, Ravit, Gou, Hongfeng, Grasselli, Julieta, Hao, Chunyi, Hatoum, Hassan, Heinemann, Volker, Jeyasingam, Vaishnavi, Jimenez Fonseca, Paula, Kasper-Virchow, Stefan, Kelley, Robin, Kim, Jong Gwang, Kinupe Abrahao, Ana Beatriz, Kochenderfer, Mark, Lee, Choong-kun, Lee, Hyun Woo, Lee, Myung Ah, Lee, Wai Man Sarah, Li, Dongliang, Liang, Houjie, Lim, Chun Sen, Low, John, Mao, Yimin, Masi, Gianluca, McCune, Steven, McWhirter, Elaine, Mendez, Guillermo, Mizutani, Tomonori, Moniz, Camila, Morales, Luisa, Munoz Martin, Andres Jesús, Oh, Sang Cheul, Painemal, Claudio, Peng, Chuang, Pezet, Denis, Roohullah, Aflah, Ryu, Hyewon, Schulze, Kornelius, Scott-Brown, Martin, Seufferlein, Thomas, Smolenschi, Cristina, Sookprasert, Aumkhae, Soparattanapaisarn, Nopadol, Starling, Naureen, Stein, Stacey, Sugimoto, Rie, Suksombooncharoen, Thatthan, Tam, Vincent, Tan, Ai Lian, Tanasanvimon, Suebpong, Tonini, Giuseppe, Tsuji, Akihito, Verslype, Chris, Victorino, Ana Paula, Wade, James, Waldschmidt, Dirk Thomas, Wang, Lu, Wan Isahk, Wan Zamaniah, Weschenfelder, Rui, Wong, Chun Yin, Yang, Xuezhong, Yau, Thomas, Zhao, Haitao

Volltext

Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer von Davis, Ian D, Martin, Andrew J, Stockler, Martin R, Begbie, Stephen, Chi, Kim N, Chowdhury, Simon, Coskinas, Xanthi, Frydenberg, Mark, Hague, Wendy E, Horvath, Lisa G, Joshua, Anthony M, Lawrence, Nicola J, Marx, Gavin, McCaffrey, John, McDermott, Ray, McJannett, Margaret, North, Scott A, Parnis, Francis, Parulekar, Wendy, Pook, David W, Reaume, M. Neil, Sandhu, Shahneen K, Tan, Alvin, Tan, T. Hsiang, Thomson, Alastair, Tu, Emily, Vera-Badillo, Francisco, Williams, Scott G, Yip, Sonia, Zhang, Alison Y, Zielinski, Robert R, Sweeney, Christopher J

Volltext

Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer von Chi, Kim N, Agarwal, Neeraj, Bjartell, Anders, Chung, Byung Ha, Pereira de Santana Gomes, Andrea J, Given, Robert, Juárez Soto, Álvaro, Merseburger, Axel S, Özgüroğlu, Mustafa, Uemura, Hirotsugu, Ye, Dingwei, Deprince, Kris, Naini, Vahid, Li, Jinhui, Cheng, Shinta, Yu, Margaret K, Zhang, Ke, Larsen, Julie S, McCarthy, Sharon, Chowdhury, Simon

Volltext

Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer von Freedland, Stephen J., de Almeida Luz, Murilo, De Giorgi, Ugo, Gleave, Martin, Gotto, Geoffrey T., Pieczonka, Christopher M., Haas, Gabriel P., Kim, Choung-Soo, Ramirez-Backhaus, Miguel, Rannikko, Antti, Tarazi, Jamal, Sridharan, Swetha, Sugg, Jennifer, Tang, Yiyun, Tutrone, Ronald F., Venugopal, Balaji, Villers, Arnauld, Woo, Henry H., Zohren, Fabian, Shore, Neal D.

Volltext

Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors von Desai, Jayesh, Gan, Hui, Barrow, Catherine, Jameson, Michael, Atkinson, Victoria, Haydon, Andrew, Millward, Michael, Begbie, Stephen, Brown, Michael, Markman, Ben, Patterson, William, Hill, Andrew, Horvath, Lisa, Nagrial, Adnan, Richardson, Gary, Jackson, Christopher, Friedlander, Michael, Parente, Phillip, Tran, Ben, Wang, Lai, Chen, Yunxin, Tang, Zhiyu, Huang, Wendy, Wu, John, Zeng, Dewan, Luo, Lusong, Solomon, Benjamin

Volltext

Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an interna... von Sweeney, Christopher J, Martin, Andrew J, Stockler, Martin R, Cheung, Leanna, Chi, Kim N, Chowdhury, Simon, Frydenberg, Mark, Joshua, Anthony M, Lawrence, Nicola J, Marx, Gavin, McCaffrey, John, McDermott, Ray, McJannett, Margaret, North, Scott A, Parnis, Francis, Parulekar, Wendy, Pook, David W, Reaume, Martin Neil, Sandhu, Shahneen K, Tan, Alvin, Tan, Thean Hsiang, Thomson, Alastair, Vera-Badillo, Francisco, Williams, Scott G, Yip, Sonia, Zielinski, Robert R, Davis, Ian D, Abdi, Ehtesham, Bastick, Patricia, Begbie, Stephen, Blum, Robert, Briscoe, Karen, Brungs, Daniel, Bydder, Sean, Chittajallu, Bala Renuka, Cronk, Michelle, Cuff, Katharine, Davis, Ian D, Dowling, Anthony, Frydenberg, Mark, Horvath, Lisa, Hovey, Elizabeth, Joshua, Anthony, Karanth, Narayan, Kichenadasse, Ganessan, Krieger, Laurence, Marx, Gavin, Mathlum, Maitham, Nott, Louise, Otty, Zulfiquer, Parnis, Francis, Pook, David, Sandhu, Shahneen, Sewak, Sanjeev, Stevanovic, Amanda, Suder, Aneta, Tan, Hsiang, Torres, Javier, Troon, Simon, Underhill, Craig, Weickhardt, Andrew, Zielinski, Robert, Anan, Ghadeer, Booth, Chris, Campbell, Holly, Chi, Kim, Chin, Joseph, Chouinard, Edmond, Drachenberg, Darrel, Faghih, Amir, Finelli, Antonio, Hotte, Sebastien, North, Scott, Rassouli, Mohammad, Reaume, Neil, Rendon, Ricardo, Saad, Fred, Sadikov, Evgeny, Vigneault, Eric, Zalewski, Pawel, McCaffrey, John, McDermott, Ray, Morris, Patrick, O'Connor, Miriam, Donnellan, Paul, Edwards, Jim, Fong, Peter, Tan, Alvin, Chowdhury, Simon, Crabb, Simon, Khan, Omar, Khoo, Vincent, Macdonald, Graham, Payne, Heather, Robinson, Angus, Shamash, Jonathon, Staffurth, John, Thomas, Carys, Thomson, Alastair, Sweeney, Christopher J

Volltext

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial von Colleoni, Marco, Luo, Weixiu, Hitre, Erika, Kamby, Claus, Müller, Bettina, Di Lauro, Vincenzo, Burstein, Harold, Bernhard, Jürg, Maibach, Rudolf, Rabaglio-Poretti, Manuela, Regan, Meredith M, Vandebroek, An, Berliere, Martine, Mitine, Carine, Vuylsteke, Peter, Glorieux, Philippe, Mebis, Jeroen, Coibion, Michael, Forget, Frederic, Duck, Lionel, Wyendaele, Wim, Pinotti, Graziella, Bernardo, Antonio, Biganzoli, Leo, Gennari, Alessandra, Forbes, John, Foo, Serene, Boyle, Frances, Abdi, Ehtesham, Na Teo, Lee, White, Shane, Gilbert, Linda, Dedes, Konstantin, Pagani, Olivia, Pedrazzini, Augusto, Rochlitz, Christoph, von Moos, Roger, Fehr, Mathias, Nyman, Per, Foukakis, Theodoros, Dabrosin, Charlotta, Fritis, Marcela, Letzkus, Jaime, Escobar, Paula, Cardemil, Juana Bernardita, Gomez, Henry, Schwartz, Joel, Bonichon-Lamichhane, Natalie, Borstner, Simona, Quispe, Oscar Zambrano, Vestlev, Peter Michael, Danø, Hella, Bews-Hair, Maria, Neades, Glyn, McKirdy, Mike, Fraser, Judith, Murphy, Dermot, Jackisch, Christian, Köcker-Korus, Heike, Stefek, Andrea, Just, Marianne, Bechtner, Christina, Grischke, Eva-Maria, Lorenz, Ralf, Dietz, Wolfgang, Thomalla, Jörg, Graf, Heiko, Busch, Steffi, Tesch, Hans, Krabisch, Petra, Rösel, Siegfried, Josten, Klaus-M, Gröll, Isolde, Mattner, Ute Marie, Garau, Isabel, Climent, Miguel Angel, López, Rafael, Bermejo, Begoña, Amillano, Kepa, Masuda, Norikazu, Toi, Masakazu, Aogi, Kenjiro, Sato, Nobuaki, Tokunaga, Eriko, Fujita, Takashi, Fridrik, Michael, Hackl, Claudia, Wette, Victor, Sevelda, Paul, Thiel, Irene, Tuttlies, Frank, Crown, John, Kennedy, John, McCaffrey, John, Murphy, Conleth, Coate, Linda, Keane, Maccon, O'Connor, Miriam, Duffy, Karen, Zardavas, Dimitrios

Volltext

Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment... von Harbeck, Nadia, Prof, Huang, Chiun-Sheng, Prof, Hurvitz, Sara, MD, Yeh, Dah-Cherng, MD, Shao, Zhimin, Prof, Im, Seock-Ah, Prof, Jung, Kyung Hae, Prof, Shen, Kunwei, MD, Ro, Jungsil, MD, Jassem, Jacek, Prof, Zhang, Qingyuan, Prof, Im, Young-Hyuck, MD, Wojtukiewicz, Marek, Prof, Sun, Qiang, MD, Chen, Shin-Cheh, Prof, Goeldner, Rainer-Georg, PhD, Uttenreuther-Fischer, Martina, MD, Xu, Binghe, Prof, Piccart-Gebhart, Martine, MD

Volltext

Overall Survival of Men with Metachronous Metastatic Hormone-sensitive Prostate Cancer Treated with Enzalutamide and Androgen Deprivation Therapy von Sweeney, Christopher J., Martin, Andrew J., Stockler, Martin R., Begbie, Stephen, Chi, Kim N., Chowdhury, Simon, Coskinas, Xanthi, Frydenberg, Mark, Hague, Wendy E., Horvath, Lisa G., Joshua, Anthony M., Lawrence, Nicola J., Marx, Gavin M., McCaffrey, John, McDermott, Ray, McJannett, Margaret, North, Scott A., Parnis, Francis, Parulekar, Wendy, Pook, David W., Reaume, M. Neil, Sandhu, Shahneen K., Tan, Alvin, Tan, Thean Hsiang, Thomson, Alastair, Tu, Emily, Vera-Badillo, Francisco, Williams, Scott G., Yip, Sonia, Zhang, Alison Y., Zielinski, Robert R., Davis, Ian D.

Volltext

Effects of a Structured Exercise Program on Physical Activity and Fitness in Colon Cancer Survivors: One Year Feasibility Results from the CHALLENGE Trial von Courneya, Kerry S, Vardy, Janette L, O'Callaghan, Christopher J, Friedenreich, Christine M, Campbell, Kristin L, Prapavessis, Harry, Crawford, Jennifer J, O'Brien, Patti, Dhillon, Haryana M, Jonker, Derek J, Chua, Neil S, Lupichuk, Sasha, Sanatani, Michael S, Gill, Sharlene, Meyer, Ralph M, Begbie, Stephen, Bonaventura, Tony, Burge, Matthew E, Turner, Jane, Tu, Dongsheng, Booth, Christopher M

Volltext

Patient-reported outcomes (PROs) in KEYLYNK-010: Pembrolizumab (pembro) plus olaparib (ola) vs abiraterone acetate (abi) or enzalutamide (enza) for patients (pts) with previously t... von Mehra, Niven, Antonarakis, Emmanuel S., Park, Se Hoon, Goh, Jeffrey C., McDermott, Raymond S., Sala González, Nuria, Fong, Peter C.C., Greil, Richard, De Santis, Maria, Yanez, Patricio Eduardo, Huang, Yi-Hsiu, Begbie, Stephen, Rey, Felipe, Kramer, Gero, Suzuki, Hiroyoshi, Saretsky, Todd L., Ghate, Sameer R., Cui, Yi, Kim, Jeri, Yu, Evan Y.

Volltext

A phase II trial of nivolumab followed by ipilimumab and nivolumab in advanced non‐clear‐cell renal cell carcinoma von Conduit, Ciara, Davis, Ian D., Goh, Jeffrey C., Kichenadasse, Ganessan, Gurney, Howard, Harris, Carole A., Pook, David, Krieger, Laurence, Parnis, Francis, Underhill, Craig, Adams, Diana, Roncolato, Felicia, Joshua, Anthony, Ferguson, Tom, Prithviraj, Prashanth, Morris, Michelle, Harrison, Michelle, Begbie, Stephen, Hovey, Elizabeth, George, Mathew, Liow, Elizabeth C., Link, Emma K., McJannett, Margaret, Gedye, Craig

Volltext

Sequential immunotherapy in rare variant renal cell carcinomafinal report of UNISoN (ANZUP 1602): Nivolumab then ipilimumab + nivolumab in advanced nonclear cell renal cell carcino... von Conduit, Ciara, Kichenadasse, Ganessan, Harris, Carole A., Gurney, Howard, Ferguson, Tom, Parnis, Francis, Goh, Jeffrey C., Morris, Michelle Frances, Underhill, Craig, Pook, David William, Davis, Ian D., Roncolato, Felicia, Harrison, Michelle L., Begbie, Stephen, Joshua, Anthony M., Link, Emma, Hovey, Elizabeth J., Gedye, Craig

Volltext

A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO tria... von Davidson, A., Veillard, A.-S., Tognela, A., Chan, M.M.K., Hughes, B.G.M., Boyer, M., Briscoe, K., Begbie, S., Abdi, E., Crombie, C., Long, J., Boyce, A., Lewis, C.R., Varma, S., Broad, A., Muljadi, N., Chinchen, S., Espinoza, D., Coskinas, X., Pavlakis, N., Millward, M., Stockler, M.R., Hughes, Brett, Boyer, Michael, Briscoe, Karen, Davidson, Andrew, Begbie, Stephen, Abdi, Ehtesham, Crombie, Catherine, Long, Jeremy, Jasas, Kevin, Lewis, Craig, Boyce, Adam, Vama, Suresh, Broad, Adam, Broaddge, Vy, Gibbs, David, Blum, Robert, McLachlan, Sue-Anne, Haydon, Andrew, Bray, Victoria, Vardy, Janette, Mallesara, Girish, Lowenthal, Ray, Asghari, Ray, Tiley, Susan, Hayes, Theresa, Islam, Mohammed, Ackland, Steven, Adams, Jacqui, Pavlakis, Nick, Stockler, Martin, Muljadi, Nick, Coskinas, Xanthi, Chinchen, Sarah, Chan, Matthew, Tognela, Annette, Ferraro, Danielle, Cosman, Rasha

Volltext

Elective hepatic resection is feasible and safe in a regional centre von Gray, Andrew D., Petrou, George, Rastogi, Pratik, Begbie, Stephen

Volltext